Groupe G SPRL
Groupe G reported total assets of 67,966 € at the end of the 2019 financial year (annual accounts filed with the NBB on 09 Nov 2020).
The score of Groupe G shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2019
Change 2016 → 2019: Equity -40 % Total assets -50 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Groupe G's annual accounts
Filed annual accounts
- Year ended 31 Dec 2019filed on 09 Nov 2020
- Year ended 31 Dec 2018filed on 06 Sep 2019
- Year ended 31 Dec 2017filed on 30 Aug 2018
- Year ended 31 Dec 2016filed on 28 Jul 2017
- Year ended 31 Dec 2015filed on 28 Jul 2016
Groupe G's financial analysis
- Solvency43.9%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Groupe G
Groupe G's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0425.994.306
- VAT number
- BE0425994306
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 09 Jul 1984
- Registered office
- 1410 Waterloo
- Latest accounts
- 2019 · filed on 09 Nov 2020
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Groupe G (SPRL) has been based in Waterloo since 1984, active in: manufacture of basic pharmaceutical products. For 2019, it reports a net profit of 8,338 € and equity of 29,860 €; its revenue is not published. Its solvency stands at 43.9%, above the median of its sector (38.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Groupe G
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- Quantoom Bioservices Manufacture of basic pharmaceutical products Nivelles · balance sheet 59,035 €
- A.T. Technique Manufacture of basic pharmaceutical products Tubize · balance sheet 50,127 €
- Regen Consulting Manufacture of basic pharmaceutical products Chaumont-Gistoux · balance sheet 104,347 €
- M.A.M. Manufacture of basic pharmaceutical products Mont-Saint-Guibert · balance sheet 136,304 €
- MAJE Manufacture of basic pharmaceutical products Genappe · balance sheet 182,851 €
- AE Clinical Biology Manufacture of basic pharmaceutical products Waterloo · balance sheet 273,294 €
- Enerpro Manufacture of basic pharmaceutical products Genappe · balance sheet 277,427 €
- 2 A Medical Manufacture of basic pharmaceutical products Wavre · balance sheet 374,588 €
Frequently asked questions about Groupe G
What is the revenue of Groupe G?
Groupe G files its accounts in a format where revenue is optional: it is not published for 2019.
What is the VAT number of Groupe G?
In Belgium, the VAT number is the company number prefixed with BE: BE0425994306 for Groupe G, if the company is VAT-registered. Its company number (CBE) is 0425.994.306.
Where is the registered office of Groupe G?
According to the CBE register, the registered office of Groupe G is in 1410 Waterloo.
What is the equity of Groupe G?
At the close of the 2019 financial year, the equity of Groupe G amounts to 29,860 €, a solvency of 43.9% of total assets.
Who manages Groupe G?
The register lists 1 active mandates at Groupe G. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Groupe G
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →